Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunoglobulin Disease”

5,413 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,413 results

Not applicableUnknownNCT05953974
What this trial is testing

Validation of a Diagnostic Score for Encephalitis to Assess the Risk of Autoimmune Origin

Who this might be right for
Autoimmune EncephalitisAutoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
Hospices Civils de Lyon 350
Large-scale testing (Phase 3)UnknownNCT03958890
What this trial is testing

A Clinical Trial Comparing HLX10 With Placebo Combined With Chemotherapy (Cisplatin + 5-fu) in the First-line Treatment of Locally Advanced/Metastatic Esophageal Squamous Cell Carcinoma (ESCC)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Shanghai Henlius Biotech 489
Not applicableStudy completedNCT00615797
What this trial is testing

Intravenous Immunoglobulins as Effective Treatment in Sydenham's Chorea

Who this might be right for
Sydenham ChoreaPost Streptococcal Movement Disorder
University of Cape Town 20
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06680596
What this trial is testing

Detecting Tumor DNA in the Blood of HR+/HER2-low Metastatic Breast Cancer Patients to Find Candidates for T-DXd Therapy

Who this might be right for
Breast Cancer MetastaticBreast Cancer Stage IV
UNICANCER 80
Testing effectiveness (Phase 2)Study completedNCT02061761
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of Relatlimab in Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Hematologic Neoplasms
Bristol-Myers Squibb 106
Not applicableStudy completedNCT04403386
What this trial is testing

Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19

Who this might be right for
COVID-19
National Institute of Environmental Health Sciences (NIEHS) 132
Early research (Phase 1)Study completedNCT01176474
What this trial is testing

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 73
Early research (Phase 1)Not Yet RecruitingNCT06633042
What this trial is testing

The Safety and Efficacy of Universal CAR-T Cells Targeting BCMA in the Treatment of Refractory NMOSD

Who this might be right for
Autoimmune Disease
Bioray Laboratories 18
Early research (Phase 1)Study completedNCT00733642
What this trial is testing

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 15
Large-scale testing (Phase 3)Study completedNCT01406470
What this trial is testing

Phase 3 Study of Immune Globulin Intravenous (Human)IVIG-SN™ in Subjects With Primary Immunodeficiency

Who this might be right for
Immunologic Deficiency Syndrome
Green Cross Corporation 45
Testing effectiveness (Phase 2)Study completedNCT00715910
What this trial is testing

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Adolescents/Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 818
Early research (Phase 1)Study completedNCT00058396
What this trial is testing

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT02632786
What this trial is testing

The PRONTO Study, a Global Phase 2b Study of NEOD001 in Previously Treated Subjects With Light Chain (AL) Amyloidosis

Who this might be right for
AL Amyloidosis
Prothena Biosciences Ltd. 129
Not applicableActive Not RecruitingNCT05571618
What this trial is testing

The Rechallenge of ADCs in MBC Patients

Who this might be right for
Breast Cancer
Fudan University 100
Testing effectiveness (Phase 2)Study completedNCT00768079
What this trial is testing

Evaluate the Safety and Efficacy of Intravenously Administered Benralizumab (MEDI-563).

Who this might be right for
Asthma
MedImmune LLC 110
Early research (Phase 1)Active Not RecruitingNCT04594642
What this trial is testing

AZD0486 in Subjects With B-Cell Non-Hodgkin Lymphoma

Who this might be right for
B-cell Non Hodgkin LymphomaDiffuse Large B Cell LymphomaHigh-grade B-cell Lymphoma+1 more
AstraZeneca 226
Post-approval studies (Phase 4)Study completedNCT01138215
What this trial is testing

The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children

Who this might be right for
HIV InfectionsVaricella-zoster Virus
The HIV Netherlands Australia Thailand Research Collaboration 60
Large-scale testing (Phase 3)Study completedNCT01302860
What this trial is testing

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Who this might be right for
Cryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more
Novartis Pharmaceuticals 17
Testing effectiveness (Phase 2)Looking for participantsNCT04199741
What this trial is testing

PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56

Who this might be right for
Small Cell Lung CancerSmall Cell Lung Carcinoma
Memorial Sloan Kettering Cancer Center 105
Not applicableLooking for participantsNCT06794073
What this trial is testing

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

Who this might be right for
Carcinoma, HepatocellularNeoplasms, Glandular and EpithelialAdenocarcinoma+2 more
Shanghai Zhongshan Hospital 17
Next Page